Tag:
dolutegravir
Latest Headlines
Latest Headlines
GSK sets stage for big late-stage drug events, potential blockbusters
GlaxoSmithKline ( $GSK ) has taken some bold steps to reconfigure its R&D operations, tackling some of the productivity issues that have plagued Big Pharma groups. Over the next year, the
Glaxo/Pfizer venture touts blockbuster potential of HIV drug
ViiV Healthcare , a joint venture of GlaxoSmithKline and Pfizer, is touting potentially blockbuster comparative data for its experimental HIV drug dolutegravir. Researchers said that the treatment
